Nerve Repair And Regeneration Market
SHARE
PUBLISHED: 2022 ID: SMRC19219
SHARE

Nerve Repair and Regeneration Market Forecasts to 2028 – Global Analysis By Product (Neurostimulation and Neuromodulation Devices, Biomaterials), End User (Hospitals, Clinics, Ambulatory Surgery Centers) and By Geography

5.0 (98 reviews)
5.0 (98 reviews)
Published: 2022 ID: SMRC19219

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Nerve Repair and Regeneration Market is accounted for $6.87 billion in 2021 and is expected to reach $14.36 billion by 2028 growing at a CAGR of 11.1% during the forecast period. Nerve repair and regeneration deals with the regrowth of nervous tissues, neurons, glial cells, myelin, synapses, axons and cell products. The mechanism for this process includes generation of new neurons, synapses, axons, glia and myelin. The complex, delicate structures that make up the nervous system-the brain, spinal cord, and peripheral nerves-are susceptible to various types of injury ranging from trauma to neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and multiple system atrophy.

Market Dynamics:

Driver:

Increasing geriatric population


There has been an increased geriatric population around the developed regions of the world. The geriatric population is at a higher risk of neurologic disorders such as stroke, neuropathy, Alzheimer’s disease, and Parkinson’s disease. Their higher susceptibility makes geriatrics a key segment of the overall patient pool. As a result, the growth of this population segment will ensure a continued, intensified demand for nerve repair and regeneration for the treatment of neurological disorders.

Restraint:

High cost of neurostimulation and neuromodulation devices


There is a significant upfront cost for the use of neuromodulation devices. The high cost of these devices may lead to disproportionate application in geographical regions with different levels of financial resources. While neurostimulation serves as an expensive up-front cost for patients and insurance companies, costs to the nation’s healthcare system, stemming from long-term issues with the treatment, are negligible. Moreover, the insurance companies cover costs for some therapies but not all. This affects the hospitals overall budget. Thus, this factor would play a significant role in hindering this market.

Opportunity:

Developing nations around the world


Developing countries such as India, China, and Brazil are expected to offer potential growth opportunities for market players during the forecast period. The huge population base, especially in India and China, is expected to be a major draw for companies in this market. This is bolstered by the rising incidence of neurological diseases like Alzheimer’s, Parkinson’s, and epilepsy. According to the World Bank, healthcare expenditure is increasing in these countries, supporting the growth of hospitals and ambulatory surgical centers in these countries. This is considered as a positive indicator for the market growth, as hospitals and ambulatory surgical centers are major end users of nerve repair and regeneration products.

Threat:

Uncertain clinical outcomes


Despite substantially increased understanding of neuropatho physiology and experimental evidence of promising neurotherapies, obtaining satisfactory clinical outcomes are challenging in cases of avulsion, crush or blast injuries of peripheral nerves. Although active rehabilitation following nerve injury may minimize the risk of disuse atrophy in muscle following nerve transaction or trauma, denervation atrophy of muscle targets is a major hurdle to nerve regeneration strategies. Even the best neuroregeneration, outcomes may be compromised due to the lack of a viable neuromuscular junction (NMJ) or muscle target leading to poor functional results.

The neurostimulation and neuromodulation devices segment is expected to be the largest during the forecast period

The neurostimulation and neuromodulation devices segment is driven by the increasing incidence of peripheral nerve injuries, technological development in the field, rising government expenditure for neurologic disorders, and favorable reimbursement. A large number of commercially available spinal cord products, investments by key companies to develop more effective devices and a wide range of applications were the factors responsible for the growth of the segment.

The hospitals segment is expected to have the highest CAGR during the forecast period

The increasing incidence of neurological disorders, the rising number of hospitals in emerging countries, and the growth and development of neuroepidemiology have been key driving factors boosting the growth of the hospital segment. Continuous monitoring is a valuable tool that helps by providing additional information to the medical and nursing staff about the physiologic condition of the patient. For instance, the Nicolet EEG Wireless Amplifier consolidates many clinical and research features into a single, portable unit for diagnosis and treatment of epilepsy, brain trauma, stroke, brain tumours, sleep dysfunction and clinical research. With the introduction of the new wireless amplifier, hospitals have a new standard of care available to them for diagnosing; monitoring and helping them treat patients with neurological disorders. This is considered as a positive indicator for the market growth, as hospitals are the major end-user of nerve repair and regeneration products.

Region with largest share:

North America is projected to hold the largest market share owing to the rising incidence of neurological disorders, favorable reimbursement policies, and the strong presence of industry players in this region. There is also the availability of technologically advanced devices that is a major factor for the dominance of this region. For instance, according to the Alzheimer's Association, number of Americans living with Alzheimer's is growing and growing fast. Moreover, the increasing government initiatives and funding and increased cases of neurological disorders, such as dementia, Alzheimer's disease and Parkinson's disease are also some of the major reasons responsible for the region’s growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the rising awareness among patients, supportive government initiatives, presence of unmet medical needs, and advent of innovative technologies. Economic growth in the countries of this region, rising prevalence of neurologic diseases, rising standard of living, growing demand for quality medical care, and increasing healthcare spending will drive the market in the region over the forecast period. China, India, Japan, Australia, and Singapore are the major countries contributing to the region’s growth.

Key players in the market

Some of the key players profiled in the Nerve Repair and Regeneration Market include Abbott Laboratories, Medtronic, Plc. , Synapse Biomedical, Inc., Baxter International, Inc., Boston Scientific Corporation , Aleva Neurotherapeutics, Neuropace, Inc., Axogen, Inc., Collagen Matrix, Inc., Integra Lifesciences, Livanova, Plc., Kerimedical, Soterix Medical, Inc., Nevro Corp., and Polyganics .

Key developments:

In February 2020: LivaNova entered into partnership with Verily (US) for evaluation of the effectiveness of Vagus Nerve Stimulation Therapy (VNS Therapy) for difficult-to-treat Depression (DTD). LivaNova and Verily aim to gather quantitative data on patient behavior using technology and analytics developed by Verily to further understand depressive episodes and a patient’s response to treatment.

In January 2020: Medtronic received CE approval for InterStim Micro neurostimulator and InterStim SureScan MRI leads, clearing the technologies for commercial sale and clinical use in Europe. The availability of the new technologies on January 15 will expand access to sacral neuromodulation (SNM) therapy for thousands of potential European patients by offering full-body MRI scan eligible, lifestyle-friendly choices with either the InterStim Micro or InterStim II neurostimulators.

In August 2019: Boston Scientific Corporation announced the U.S. Food and Drug Administration (FDA) approval of its ImageReady™ MRI labeling for the Vercise Gevia™  Deep Brain Stimulation (DBS) System to be used in a full-body magnetic resonance imaging (MRI) environment. This system, with the Vercise Cartesia™ Directional Lead, is designed to treat the symptoms of Parkinson's Disease (PD) by delivering precisely targeted electrical stimulation in the brain to provide optimal symptom relief and better control of unwanted side effects.

Products Covered:
• Neurostimulation and Neuromodulation Devices
• Biomaterials

Applications Covered:
• Direct Nerve Repair/Neurorrhaphy
• Stem Cell Therapy
• Neurostimulation and Neuromodulation Surgeries
• Nerve Grafting

End Users Covered:
• Hospitals
• Clinics
• Ambulatory Surgery Centers

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary      
        
2 Preface       

 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis     
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints      
 3.4 Opportunities     
 3.5 Threats      
 3.6 Product Analysis     
 3.7 Application Analysis     
 3.8 End User Analysis     
 3.9 Emerging Markets     
 3.10 Impact of Covid-19     
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes     
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Nerve Repair and Regeneration Market, By Product  
 5.1 Introduction     
 5.2 Neurostimulation and Neuromodulation Devices  
  5.2.1 External Neurostimulation Devices  
   5.2.1.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
   5.2.1.2 Transcranial Magnetic Stimulation (TMS) Devices
   5.2.1.3 Respiratory electric stimulation (RES) devices
  5.2.2 Internal Neurostimulation Devices  
   5.2.2.1 Spinal Cord Stimulation (SCS)  
   5.2.2.2 Vagus Nerve Stimulation (VNS)  
   5.2.2.3 Deep Brain Stimulation (DBS)  
   5.2.2.4 Sacral Nerve Stimulation (SNS)  
   5.2.2.5 Gastric Electrical Stimulation (GES) 
 5.3 Biomaterials     
  5.3.1 Nerve Protectors    
  5.3.2 Nerve Connectors    
  5.3.3 Nerve Wraps    
  5.3.4 Nerve Conduits    
        
6 Global Nerve Repair and Regeneration Market, By Application  
 6.1 Introduction     
 6.2 Direct Nerve Repair/Neurorrhaphy   
  6.2.1 Perineural Repair    
  6.2.2 Epineural Repair    
  6.2.3 Group Fascicular Repair   
 6.3 Stem Cell Therapy     
 6.4 Neurostimulation and Neuromodulation Surgeries  
  6.4.1 External Neurostimulation and Neuromodulation Surgeries
  6.4.2 Internal Neurostimulation and Neuromodulation Surgeries
 6.5 Nerve Grafting     
  6.5.1 Allografts     
  6.5.2 Autografts    
  6.5.3 Xenografts    
        
7 Global Nerve Repair and Regeneration Market, By End User  
 7.1 Introduction     
 7.2 Hospitals      
 7.3 Clinics      
 7.4 Ambulatory Surgery Centers    
        
8 Global Nerve Repair and Regeneration Market, By Geography  
 8.1 Introduction     
 8.2 North America     
  8.2.1 US     
  8.2.2 Canada     
  8.2.3 Mexico     
 8.3 Europe      
  8.3.1 Germany     
  8.3.2 UK     
  8.3.3 Italy     
  8.3.4 France     
  8.3.5 Spain     
  8.3.6 Rest of Europe    
 8.4 Asia Pacific     
  8.4.1 Japan     
  8.4.2 China     
  8.4.3 India     
  8.4.4 Australia     
  8.4.5 New Zealand    
  8.4.6 South Korea    
  8.4.7 Rest of Asia Pacific    
 8.5 South America     
  8.5.1 Argentina     
  8.5.2 Brazil      
  8.5.3 Chile     
  8.5.4 Rest of South America   
 8.6 Middle East & Africa     
  8.6.1 Saudi Arabia    
  8.6.2 UAE     
  8.6.3 Qatar     
  8.6.4 South Africa    
  8.6.5 Rest of Middle East & Africa   
        
9 Key Developments      
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 9.2 Acquisitions & Mergers    
 9.3 New Product Launch     
 9.4 Expansions     
 9.5 Other Key Strategies     
        
10 Company Profiling      
 10.1 Abbott Laboratories     
 10.2 Medtronic, Plc.     
 10.3 Synapse Biomedical, Inc.    
 10.4 Baxter International, Inc.    
 10.5 Boston Scientific Corporation    
 10.6 Aleva Neurotherapeutics    
 10.7 Neuropace, Inc.     
 10.8 Axogen, Inc.     
 10.9 Collagen Matrix, Inc.     
 10.10 Integra Lifesciences     
 10.11 Livanova, Plc.     
 10.12 Kerimedical     
 10.13 Soterix Medical, Inc.     
 10.14 Nevro Corp.     
 10.15 Polyganics     


List of Tables       
1 Global Nerve Repair and Regeneration Market Outlook, By Region (2020-2028) ($MN)
2 Global Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
3 Global Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
4 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
5 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
6 Global Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
7 Global Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
8 Global Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
9 Global Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
10 Global Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
11 Global Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
12 Global Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
13 Global Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
14 Global Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
15 Global Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
16 Global Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
17 Global Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
18 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
19 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
20 Global Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
21 Global Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
22 Global Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
23 Global Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
24 Global Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
25 Global Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
26 Global Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
27 Global Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
28 North America Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
29 North America Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
30 North America Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
31 North America Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
32 North America Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
33 North America Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
34 North America Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
35 North America Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
36 North America Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
37 North America Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
38 North America Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
39 North America Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
40 North America Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
41 North America Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
42 North America Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
43 North America Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
44 North America Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
45 North America Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
46 North America Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
47 North America Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
48 North America Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
49 North America Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
50 North America Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
51 North America Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
52 North America Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
53 North America Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
54 North America Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
55 Europe Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
56 Europe Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
57 Europe Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
58 Europe Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
59 Europe Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
60 Europe Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
61 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
62 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
63 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
64 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
65 Europe Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
66 Europe Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
67 Europe Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
68 Europe Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
69 Europe Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
70 Europe Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
71 Europe Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
72 Europe Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
73 Europe Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
74 Europe Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
75 Europe Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
76 Europe Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
77 Europe Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
78 Europe Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
79 Europe Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
80 Europe Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
81 Europe Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
82 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
83 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
84 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
85 Asia Pacific Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
86 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
87 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
88 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
89 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
90 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
91 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
92 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
93 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
94 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
95 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
96 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
97 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
98 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
99 Asia Pacific Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
100 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
101 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
102 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
103 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
104 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
105 Asia Pacific Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
106 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
107 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
108 Asia Pacific Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
109 South America Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
110 South America Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
111 South America Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
112 South America Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
113 South America Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
114 South America Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
115 South America Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
116 South America Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
117 South America Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
118 South America Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
119 South America Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
120 South America Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
121 South America Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
122 South America Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
123 South America Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
124 South America Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
125 South America Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
126 South America Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
127 South America Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
128 South America Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
129 South America Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
130 South America Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
131 South America Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
132 South America Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
133 South America Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
134 South America Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
135 South America Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)
136 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Country (2020-2028) ($MN)
137 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Product (2020-2028) ($MN)
138 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Devices (2020-2028) ($MN)
139 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2020-2028) ($MN)
140 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2020-2028) ($MN)
141 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Biomaterials (2020-2028) ($MN)
142 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2020-2028) ($MN)
143 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2020-2028) ($MN)
144 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2020-2028) ($MN)
145 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2020-2028) ($MN)
146 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Application (2020-2028) ($MN)
147 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair/Neurorrhaphy (2020-2028) ($MN)
148 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2020-2028) ($MN)
149 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2020-2028) ($MN)
150 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2020-2028) ($MN)
151 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2020-2028) ($MN)
152 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
153 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By External Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
154 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation and Neuromodulation Surgeries (2020-2028) ($MN)
155 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2020-2028) ($MN)
156 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Allografts (2020-2028) ($MN)
157 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Autografts (2020-2028) ($MN)
158 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Xenografts (2020-2028) ($MN)
159 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By End User (2020-2028) ($MN)
160 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Hospitals (2020-2028) ($MN)
161 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Clinics (2020-2028) ($MN)
162 Middle East & Africa Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgery Centers (2020-2028) ($MN)

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials